nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenamide—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.124	0.601	CbGbCtD
Diclofenamide—CYP2C9—Progesterone—uterine cancer	0.0823	0.398	CbGbCtD
Diclofenamide—CA6—exocrine gland—uterine cancer	0.0323	0.169	CbGeAlD
Diclofenamide—Digestion impaired—Progesterone—uterine cancer	0.021	0.0349	CcSEcCtD
Diclofenamide—Digestion impaired—Medroxyprogesterone Acetate—uterine cancer	0.019	0.0316	CcSEcCtD
Diclofenamide—Metabolic acidosis—Etoposide—uterine cancer	0.0182	0.0302	CcSEcCtD
Diclofenamide—CA5A—female reproductive system—uterine cancer	0.0162	0.0847	CbGeAlD
Diclofenamide—Eruption—Dactinomycin—uterine cancer	0.0161	0.0268	CcSEcCtD
Diclofenamide—Nephrolithiasis—Medroxyprogesterone Acetate—uterine cancer	0.0158	0.0263	CcSEcCtD
Diclofenamide—CA7—renal system—uterine cancer	0.0135	0.0704	CbGeAlD
Diclofenamide—Disorientation—Progesterone—uterine cancer	0.0114	0.0189	CcSEcCtD
Diclofenamide—Hepatic failure—Progesterone—uterine cancer	0.0113	0.0188	CcSEcCtD
Diclofenamide—CA2—exocrine gland—uterine cancer	0.0111	0.0582	CbGeAlD
Diclofenamide—Hepatic failure—Medroxyprogesterone Acetate—uterine cancer	0.0103	0.0171	CcSEcCtD
Diclofenamide—CA9—female reproductive system—uterine cancer	0.00947	0.0495	CbGeAlD
Diclofenamide—CA12—renal system—uterine cancer	0.00874	0.0457	CbGeAlD
Diclofenamide—Ataxia—Medroxyprogesterone Acetate—uterine cancer	0.00868	0.0144	CcSEcCtD
Diclofenamide—Hypokalaemia—Medroxyprogesterone Acetate—uterine cancer	0.00841	0.014	CcSEcCtD
Diclofenamide—Pollakiuria—Progesterone—uterine cancer	0.00814	0.0135	CcSEcCtD
Diclofenamide—Hepatic failure—Dactinomycin—uterine cancer	0.00802	0.0133	CcSEcCtD
Diclofenamide—Weight decreased—Progesterone—uterine cancer	0.00797	0.0132	CcSEcCtD
Diclofenamide—Drowsiness—Progesterone—uterine cancer	0.00785	0.013	CcSEcCtD
Diclofenamide—Hyperuricaemia—Etoposide—uterine cancer	0.00774	0.0129	CcSEcCtD
Diclofenamide—Body temperature increased—Carboplatin—uterine cancer	0.00754	0.0125	CcSEcCtD
Diclofenamide—Pollakiuria—Medroxyprogesterone Acetate—uterine cancer	0.00737	0.0122	CcSEcCtD
Diclofenamide—CA5B—mammalian vulva—uterine cancer	0.00733	0.0384	CbGeAlD
Diclofenamide—Blood uric acid increased—Etoposide—uterine cancer	0.00731	0.0121	CcSEcCtD
Diclofenamide—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.00722	0.012	CcSEcCtD
Diclofenamide—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00712	0.0118	CcSEcCtD
Diclofenamide—CA12—female reproductive system—uterine cancer	0.007	0.0366	CbGeAlD
Diclofenamide—CA1—renal system—uterine cancer	0.00693	0.0362	CbGeAlD
Diclofenamide—Tinnitus—Progesterone—uterine cancer	0.00657	0.0109	CcSEcCtD
Diclofenamide—Eruption—Epirubicin—uterine cancer	0.00655	0.0109	CcSEcCtD
Diclofenamide—CA5B—female reproductive system—uterine cancer	0.00628	0.0328	CbGeAlD
Diclofenamide—Eruption—Doxorubicin—uterine cancer	0.00606	0.0101	CcSEcCtD
Diclofenamide—Tension—Progesterone—uterine cancer	0.00602	0.01	CcSEcCtD
Diclofenamide—Nervousness—Progesterone—uterine cancer	0.00596	0.0099	CcSEcCtD
Diclofenamide—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.00596	0.00989	CcSEcCtD
Diclofenamide—Tremor—Progesterone—uterine cancer	0.00575	0.00955	CcSEcCtD
Diclofenamide—CA5B—vagina—uterine cancer	0.00568	0.0297	CbGeAlD
Diclofenamide—CA1—female reproductive system—uterine cancer	0.00555	0.029	CbGeAlD
Diclofenamide—Tension—Medroxyprogesterone Acetate—uterine cancer	0.00546	0.00907	CcSEcCtD
Diclofenamide—CA4—renal system—uterine cancer	0.00541	0.0283	CbGeAlD
Diclofenamide—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.0054	0.00897	CcSEcCtD
Diclofenamide—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00521	0.00865	CcSEcCtD
Diclofenamide—Agranulocytosis—Dactinomycin—uterine cancer	0.00518	0.0086	CcSEcCtD
Diclofenamide—Confusional state—Progesterone—uterine cancer	0.00505	0.00839	CcSEcCtD
Diclofenamide—CA2—epithelium—uterine cancer	0.00484	0.0253	CbGeAlD
Diclofenamide—Anorexia—Progesterone—uterine cancer	0.00478	0.00793	CcSEcCtD
Diclofenamide—CA2—smooth muscle tissue—uterine cancer	0.00466	0.0244	CbGeAlD
Diclofenamide—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00458	0.0076	CcSEcCtD
Diclofenamide—CA2—decidua—uterine cancer	0.00457	0.0239	CbGeAlD
Diclofenamide—Paraesthesia—Progesterone—uterine cancer	0.0045	0.00747	CcSEcCtD
Diclofenamide—CA2—renal system—uterine cancer	0.00449	0.0235	CbGeAlD
Diclofenamide—Somnolence—Progesterone—uterine cancer	0.00445	0.0074	CcSEcCtD
Diclofenamide—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00444	0.00738	CcSEcCtD
Diclofenamide—Dyspepsia—Progesterone—uterine cancer	0.00441	0.00732	CcSEcCtD
Diclofenamide—Decreased appetite—Progesterone—uterine cancer	0.00435	0.00723	CcSEcCtD
Diclofenamide—Hyperuricaemia—Epirubicin—uterine cancer	0.00434	0.00721	CcSEcCtD
Diclofenamide—CA4—female reproductive system—uterine cancer	0.00434	0.0227	CbGeAlD
Diclofenamide—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00433	0.00719	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Progesterone—uterine cancer	0.00432	0.00718	CcSEcCtD
Diclofenamide—Fatigue—Progesterone—uterine cancer	0.00432	0.00717	CcSEcCtD
Diclofenamide—Constipation—Progesterone—uterine cancer	0.00428	0.00711	CcSEcCtD
Diclofenamide—CA2—mammalian vulva—uterine cancer	0.0042	0.022	CbGeAlD
Diclofenamide—Feeling abnormal—Progesterone—uterine cancer	0.00413	0.00686	CcSEcCtD
Diclofenamide—Blood uric acid increased—Epirubicin—uterine cancer	0.0041	0.00681	CcSEcCtD
Diclofenamide—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00408	0.00677	CcSEcCtD
Diclofenamide—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00404	0.0067	CcSEcCtD
Diclofenamide—Hyperuricaemia—Doxorubicin—uterine cancer	0.00402	0.00667	CcSEcCtD
Diclofenamide—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.004	0.00664	CcSEcCtD
Diclofenamide—Body temperature increased—Progesterone—uterine cancer	0.00396	0.00658	CcSEcCtD
Diclofenamide—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00395	0.00655	CcSEcCtD
Diclofenamide—CA4—female gonad—uterine cancer	0.00395	0.0206	CbGeAlD
Diclofenamide—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00392	0.00651	CcSEcCtD
Diclofenamide—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00391	0.0065	CcSEcCtD
Diclofenamide—Leukopenia—Dactinomycin—uterine cancer	0.00388	0.00645	CcSEcCtD
Diclofenamide—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00388	0.00645	CcSEcCtD
Diclofenamide—Blood uric acid increased—Doxorubicin—uterine cancer	0.00379	0.0063	CcSEcCtD
Diclofenamide—Agranulocytosis—Etoposide—uterine cancer	0.00375	0.00623	CcSEcCtD
Diclofenamide—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00374	0.00621	CcSEcCtD
Diclofenamide—CA5B—lymph node—uterine cancer	0.00367	0.0192	CbGeAlD
Diclofenamide—CA2—female reproductive system—uterine cancer	0.0036	0.0188	CbGeAlD
Diclofenamide—Asthenia—Progesterone—uterine cancer	0.00359	0.00597	CcSEcCtD
Diclofenamide—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00359	0.00596	CcSEcCtD
Diclofenamide—Pruritus—Progesterone—uterine cancer	0.00354	0.00589	CcSEcCtD
Diclofenamide—Thrombocytopenia—Dactinomycin—uterine cancer	0.00347	0.00576	CcSEcCtD
Diclofenamide—Anorexia—Dactinomycin—uterine cancer	0.00338	0.00561	CcSEcCtD
Diclofenamide—Dizziness—Progesterone—uterine cancer	0.00331	0.0055	CcSEcCtD
Diclofenamide—CA2—female gonad—uterine cancer	0.00327	0.0171	CbGeAlD
Diclofenamide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00326	0.00541	CcSEcCtD
Diclofenamide—Hepatic failure—Epirubicin—uterine cancer	0.00325	0.0054	CcSEcCtD
Diclofenamide—CA2—vagina—uterine cancer	0.00325	0.017	CbGeAlD
Diclofenamide—CA1—lymph node—uterine cancer	0.00324	0.017	CbGeAlD
Diclofenamide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00321	0.00533	CcSEcCtD
Diclofenamide—Vomiting—Progesterone—uterine cancer	0.00319	0.00529	CcSEcCtD
Diclofenamide—Rash—Progesterone—uterine cancer	0.00316	0.00525	CcSEcCtD
Diclofenamide—Headache—Progesterone—uterine cancer	0.00314	0.00521	CcSEcCtD
Diclofenamide—Decreased appetite—Dactinomycin—uterine cancer	0.00308	0.00511	CcSEcCtD
Diclofenamide—Fatigue—Dactinomycin—uterine cancer	0.00305	0.00507	CcSEcCtD
Diclofenamide—CYP2C9—female reproductive system—uterine cancer	0.00304	0.0159	CbGeAlD
Diclofenamide—Hepatic failure—Doxorubicin—uterine cancer	0.00301	0.005	CcSEcCtD
Diclofenamide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.003	0.00499	CcSEcCtD
Diclofenamide—Nausea—Progesterone—uterine cancer	0.00298	0.00494	CcSEcCtD
Diclofenamide—Feeling abnormal—Dactinomycin—uterine cancer	0.00292	0.00485	CcSEcCtD
Diclofenamide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00289	0.00479	CcSEcCtD
Diclofenamide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00286	0.00475	CcSEcCtD
Diclofenamide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00284	0.00472	CcSEcCtD
Diclofenamide—Leukopenia—Etoposide—uterine cancer	0.00281	0.00467	CcSEcCtD
Diclofenamide—Body temperature increased—Dactinomycin—uterine cancer	0.0028	0.00465	CcSEcCtD
Diclofenamide—Ataxia—Epirubicin—uterine cancer	0.00275	0.00456	CcSEcCtD
Diclofenamide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.0027	0.00448	CcSEcCtD
Diclofenamide—Hypokalaemia—Epirubicin—uterine cancer	0.00266	0.00442	CcSEcCtD
Diclofenamide—Confusional state—Etoposide—uterine cancer	0.00258	0.00429	CcSEcCtD
Diclofenamide—Ataxia—Doxorubicin—uterine cancer	0.00254	0.00422	CcSEcCtD
Diclofenamide—Asthenia—Dactinomycin—uterine cancer	0.00254	0.00422	CcSEcCtD
Diclofenamide—CA4—lymph node—uterine cancer	0.00254	0.0133	CbGeAlD
Diclofenamide—Thrombocytopenia—Etoposide—uterine cancer	0.00251	0.00417	CcSEcCtD
Diclofenamide—Hypokalaemia—Doxorubicin—uterine cancer	0.00246	0.00409	CcSEcCtD
Diclofenamide—Anorexia—Etoposide—uterine cancer	0.00244	0.00406	CcSEcCtD
Diclofenamide—Pollakiuria—Epirubicin—uterine cancer	0.00233	0.00388	CcSEcCtD
Diclofenamide—Paraesthesia—Etoposide—uterine cancer	0.0023	0.00382	CcSEcCtD
Diclofenamide—Weight decreased—Epirubicin—uterine cancer	0.00229	0.0038	CcSEcCtD
Diclofenamide—Somnolence—Etoposide—uterine cancer	0.00228	0.00378	CcSEcCtD
Diclofenamide—Drowsiness—Epirubicin—uterine cancer	0.00225	0.00374	CcSEcCtD
Diclofenamide—Vomiting—Dactinomycin—uterine cancer	0.00225	0.00374	CcSEcCtD
Diclofenamide—Rash—Dactinomycin—uterine cancer	0.00223	0.00371	CcSEcCtD
Diclofenamide—Decreased appetite—Etoposide—uterine cancer	0.00223	0.0037	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Etoposide—uterine cancer	0.00221	0.00367	CcSEcCtD
Diclofenamide—Fatigue—Etoposide—uterine cancer	0.00221	0.00367	CcSEcCtD
Diclofenamide—Constipation—Etoposide—uterine cancer	0.00219	0.00364	CcSEcCtD
Diclofenamide—Pollakiuria—Doxorubicin—uterine cancer	0.00216	0.00359	CcSEcCtD
Diclofenamide—Weight decreased—Doxorubicin—uterine cancer	0.00211	0.00351	CcSEcCtD
Diclofenamide—Feeling abnormal—Etoposide—uterine cancer	0.00211	0.00351	CcSEcCtD
Diclofenamide—Nausea—Dactinomycin—uterine cancer	0.0021	0.00349	CcSEcCtD
Diclofenamide—CA2—lymph node—uterine cancer	0.0021	0.011	CbGeAlD
Diclofenamide—Agranulocytosis—Epirubicin—uterine cancer	0.0021	0.00349	CcSEcCtD
Diclofenamide—Drowsiness—Doxorubicin—uterine cancer	0.00208	0.00346	CcSEcCtD
Diclofenamide—Body temperature increased—Etoposide—uterine cancer	0.00203	0.00336	CcSEcCtD
Diclofenamide—Agranulocytosis—Doxorubicin—uterine cancer	0.00194	0.00323	CcSEcCtD
Diclofenamide—Tinnitus—Epirubicin—uterine cancer	0.00189	0.00313	CcSEcCtD
Diclofenamide—Asthenia—Etoposide—uterine cancer	0.00184	0.00305	CcSEcCtD
Diclofenamide—Pruritus—Etoposide—uterine cancer	0.00181	0.00301	CcSEcCtD
Diclofenamide—Tinnitus—Doxorubicin—uterine cancer	0.00174	0.0029	CcSEcCtD
Diclofenamide—Tension—Epirubicin—uterine cancer	0.00173	0.00287	CcSEcCtD
Diclofenamide—Nervousness—Epirubicin—uterine cancer	0.00171	0.00284	CcSEcCtD
Diclofenamide—Dizziness—Etoposide—uterine cancer	0.00169	0.00281	CcSEcCtD
Diclofenamide—Vomiting—Etoposide—uterine cancer	0.00163	0.00271	CcSEcCtD
Diclofenamide—Rash—Etoposide—uterine cancer	0.00162	0.00268	CcSEcCtD
Diclofenamide—Headache—Etoposide—uterine cancer	0.00161	0.00267	CcSEcCtD
Diclofenamide—Tension—Doxorubicin—uterine cancer	0.0016	0.00265	CcSEcCtD
Diclofenamide—Nervousness—Doxorubicin—uterine cancer	0.00158	0.00263	CcSEcCtD
Diclofenamide—Leukopenia—Epirubicin—uterine cancer	0.00158	0.00262	CcSEcCtD
Diclofenamide—Nausea—Etoposide—uterine cancer	0.00152	0.00253	CcSEcCtD
Diclofenamide—Leukopenia—Doxorubicin—uterine cancer	0.00146	0.00242	CcSEcCtD
Diclofenamide—Confusional state—Epirubicin—uterine cancer	0.00145	0.00241	CcSEcCtD
Diclofenamide—Thrombocytopenia—Epirubicin—uterine cancer	0.00141	0.00234	CcSEcCtD
Diclofenamide—Anorexia—Epirubicin—uterine cancer	0.00137	0.00227	CcSEcCtD
Diclofenamide—Confusional state—Doxorubicin—uterine cancer	0.00134	0.00223	CcSEcCtD
Diclofenamide—Thrombocytopenia—Doxorubicin—uterine cancer	0.0013	0.00216	CcSEcCtD
Diclofenamide—Paraesthesia—Epirubicin—uterine cancer	0.00129	0.00214	CcSEcCtD
Diclofenamide—Somnolence—Epirubicin—uterine cancer	0.00128	0.00212	CcSEcCtD
Diclofenamide—Anorexia—Doxorubicin—uterine cancer	0.00127	0.0021	CcSEcCtD
Diclofenamide—Dyspepsia—Epirubicin—uterine cancer	0.00126	0.0021	CcSEcCtD
Diclofenamide—Decreased appetite—Epirubicin—uterine cancer	0.00125	0.00207	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00124	0.00206	CcSEcCtD
Diclofenamide—Fatigue—Epirubicin—uterine cancer	0.00124	0.00206	CcSEcCtD
Diclofenamide—Constipation—Epirubicin—uterine cancer	0.00123	0.00204	CcSEcCtD
Diclofenamide—Paraesthesia—Doxorubicin—uterine cancer	0.00119	0.00198	CcSEcCtD
Diclofenamide—Feeling abnormal—Epirubicin—uterine cancer	0.00118	0.00197	CcSEcCtD
Diclofenamide—Somnolence—Doxorubicin—uterine cancer	0.00118	0.00196	CcSEcCtD
Diclofenamide—Dyspepsia—Doxorubicin—uterine cancer	0.00117	0.00194	CcSEcCtD
Diclofenamide—Decreased appetite—Doxorubicin—uterine cancer	0.00116	0.00192	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.00115	0.00191	CcSEcCtD
Diclofenamide—Fatigue—Doxorubicin—uterine cancer	0.00115	0.0019	CcSEcCtD
Diclofenamide—Constipation—Doxorubicin—uterine cancer	0.00114	0.00189	CcSEcCtD
Diclofenamide—Body temperature increased—Epirubicin—uterine cancer	0.00114	0.00189	CcSEcCtD
Diclofenamide—Feeling abnormal—Doxorubicin—uterine cancer	0.0011	0.00182	CcSEcCtD
Diclofenamide—Body temperature increased—Doxorubicin—uterine cancer	0.00105	0.00175	CcSEcCtD
Diclofenamide—Asthenia—Epirubicin—uterine cancer	0.00103	0.00171	CcSEcCtD
Diclofenamide—Pruritus—Epirubicin—uterine cancer	0.00102	0.00169	CcSEcCtD
Diclofenamide—Asthenia—Doxorubicin—uterine cancer	0.000954	0.00158	CcSEcCtD
Diclofenamide—Dizziness—Epirubicin—uterine cancer	0.00095	0.00158	CcSEcCtD
Diclofenamide—Pruritus—Doxorubicin—uterine cancer	0.00094	0.00156	CcSEcCtD
Diclofenamide—Vomiting—Epirubicin—uterine cancer	0.000913	0.00152	CcSEcCtD
Diclofenamide—Rash—Epirubicin—uterine cancer	0.000906	0.0015	CcSEcCtD
Diclofenamide—Headache—Epirubicin—uterine cancer	0.0009	0.00149	CcSEcCtD
Diclofenamide—Dizziness—Doxorubicin—uterine cancer	0.000879	0.00146	CcSEcCtD
Diclofenamide—Nausea—Epirubicin—uterine cancer	0.000853	0.00142	CcSEcCtD
Diclofenamide—Vomiting—Doxorubicin—uterine cancer	0.000845	0.0014	CcSEcCtD
Diclofenamide—Rash—Doxorubicin—uterine cancer	0.000838	0.00139	CcSEcCtD
Diclofenamide—Headache—Doxorubicin—uterine cancer	0.000833	0.00138	CcSEcCtD
Diclofenamide—Nausea—Doxorubicin—uterine cancer	0.00079	0.00131	CcSEcCtD
